Technology
Health
Pharmaceutical
Sonoma Pharmaceuticals
$0.999876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0006 (-0.06%) Today
+$0.0099 (1.01%) After Hours
Why Robinhood?
You can buy or sell SNOA and other stocks, options, ETFs, and crypto commission-free!
About
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Read More Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.
Employees
217
Headquarters
Petaluma, California
Founded
1999
Market Cap
11.74M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
145.74K
High Today
$1.00
Low Today
$0.98
Open Price
$1.00
Volume
26.70K
52 Week High
$4.80
52 Week Low
$0.6399
Collections
Technology
Health
Pharmaceutical
Healthcare
US
North America
News
Markets InsiderMar 12
Sonoma Pharmaceuticals Announces Substantial Cost-Cutting Measures
PETALUMA, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced substantial cost-cutting measures, including reductions to the company’s workforce and management. The measures come on the heels of Sonoma’s highest revenue quarter ended December 31, 2018. Total revenues were $5.3 million in the quarter ended December 31, 2018, the highest in company history, an increase of 9% compared to the quarter ended December 31, 2017,...
Simply Wall StMar 8
Easy Come, Easy Go: How Sonoma Pharmaceuticals (NASDAQ:SNOA) Shareholders Torched 96% Of Their Cash
While it may not be enough for some shareholders, we think it is good to see the Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) share price up 23% in a single quarter. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. In fact, the share price has tumbled down a mountain to land 96% lower after that period. While the recent increase might be a green shoot, we’re certainly hesitant to rejoice. The million dollar question is whether the company can justify a long term recovery. While...
Price Paid on Robinhood
47% Lower
Right Now
52 Week Low
$0.6399
Average Price Paid
$1.86
52 Week High
$4.80
Earnings
-$0.93
-$0.71
-$0.48
-$0.26
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Jun 13, After Hours